Bioequivalence Study Comparing Linezolid 600 Mg Oral Suspension With 600 Mg Tablet In Chinese Healthy Male Subjects
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to estimate the bioequivalence comparing Linezolid 600 MG Oral
Suspension with 600 MG tablet in Chinese healthy male subjects. This study data will be used
to support Linezolid OS NDA in China.